GS
ABBV icon

Girard Securities’s AbbVie ABBV Stock Holding History

Girard Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,218
Closed -$307K – 133
2017
Q2 		$307K Sell
4,218
-202
-5% -$13.6K 0.23% 108
2017
Q1 		$288K Sell
4,420
-2,424
-35% -$152K 0.25% 108
2016
Q4 		$429K Buy
6,844
+975
+17% +$59.5K 0.37% 80
2016
Q3 		$370K Buy
5,869
+897
+18% +$58.1K 0.38% 75
2016
Q2 		$307K Buy
4,972
+79
+2% +$4.81K 0.28% 104
2016
Q1 		$278K Buy
4,893
+5
+0.1% +$279 0.27% 109
2015
Q4 		$290K Buy
+4,888
New +$282K 0.29% 106

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Girard Securities's ABBV Position: Q3 2017 in Review

Girard Securities sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 4,218 shares — an estimated $307K sold.

Girard Securities first reported a position in ABBV in Q4 2015 and held it in 7 quarters. The position peaked at $429K in Q4 2016. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Girard Securities reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
  • Girard Securities sold 4,218 AbbVie shares in Q3 2017, an estimated $307K.
  • Girard Securities first reported a position in AbbVie in Q4 2015 and held it in 7 quarters.
  • Girard Securities's AbbVie position peaked at $429K in Q4 2016.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Girard Securities's 13F filing for Q3 2017, filed 14 Nov 2017.